1.
Guy D, Glicksman R, Buckley R, Cheung P, Chung H, Flax S, Hajek D, Loblaw A, Morton G, Noakes J, Spevack L, Chin JL, Rodrigues G. Metastatic progression following multimodal therapy for unfavorable-risk prostate cancer. CUAJ [Internet]. 2021 Nov. 18 [cited 2024 Apr. 26];16(4):E220-6. Available from: https://cuaj.ca/index.php/journal/article/view/7525